The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: ValiRx reports narrowed loss; McBride revenue slips

Tue, 07th Sep 2021 15:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

ValiRx PLC - life science company - Reports narrowed pretax loss of GBP785,434 for the six months to the end of June versus GBP884,523 posted a year before. ValiRX says its administrative expenses reduced to GBP618,228 from GBP791,866 a year earlier, but research & developments costs rose to GBP166,500 from GBP99,879. "I look forward to continued progress with our existing projects and the opportunity to build on our concept of connected innovation," says Non-Executive Chair Kevin Cox.

----------

McBride PLC - domestic household products manufacturer - Reports revenue decline of 3.4% for the year to the end of June to GBP682.3 million from GBP706.2 million posted in financial 2020. On a constant currency basis, revenue falls by 4.0% year-on-year. Pretax profit, however, climbs to GBP11.3 million from GBP11.2 million the year prior amid reduction in administrative costs to GBP165.2 million from GBP168.3 million. McBride reviews its dividend policy as part of its strategy reset, with no final dividend proposed, unchanged year-on-year. "We continue to anticipate a weak first half year, especially when compared to our strong first half last year, with profits therefore heavily weighted to the second half of the year," says Chief Executive Chris Smith.

----------

Alumasc Group PLC - building products supplier - Reports 19% growth in revenue from continuing operations to GBP90.5 million for the financial year to June 30 from GBP76.0 million the year ago. Pretax profit, meanwhile, jumps to GBP9.8 million from GBP2.7 million year-on-year. The company declares final dividend of 6.25 pence a share, taking a full-year payout to 9.5p, up from 2.0p paid the year before. "I am delighted to report this excellent set of results to our shareholders and believe Alumasc is well-positioned to benefit from the long-term growth drivers in our market," says CEO Paul Hooper.

----------

DP Eurasia NV - Netherlands-based pizza delivery company - Reports system sales for the six months to June 30 of TRY1.05 billion, about GBP91.5 million, up 58% year-on-year. System sales like-for-like growth totals 18% in the half year. Revenue rises by 50% to TRY658.0 million. Full year guidance for Turkey like-for-like raised to 35% - 40% from 21% - 25% guided previously, and adjusted earnings before interest, tax, depreciation and amortisation expected to be slightly ahead of current market expectations, the company notes. "Digital continues to be the driving force behind our sales with the digital mix in delivery reaching record levels in both Turkey and Russia for the first half of the year," says CEO Aslan Saranga. Online delivery system sales as a share of delivery system sales stood at 78% for the half year, rising from 75% a year before.

----------

Luceco PLC - LED lighting manufacturer and distributor - Posts revenue growth of 51% for the six months to the end of June to GBP108.2 million from GBP71.6 million recorded a year earlier. On a constant currency basis, revenue is up 58% year-on-year. Pretax profit almost doubles to GBP16.6 million from GBP8.4 million the year prior. Luceco declares dividend of 2.6p a share, up from 1.5p paid the year before. "The group has outperformed the market throughout its history thanks to its leading brands, strong channel relationships, well-invested product innovation and operational agility. The competitive advantages of our business model have been accentuated during Covid, accelerating our market share gains," says CEO John Hornby.

----------

GRC International Group PLC - supplier of cyber security, risk management and compliance products - Reports revenue for the financial year to March 31 down 16% to GBP11.8 million from GBP14.1 million due to the pandemic. However, pretax loss narrowed to GBP2.8 million from GBP3.7 million year-on-year. This is due to a reduction in total administrative expenses to GBP8.9 million from GBP11.6 million the year prior. Going forward, the company says positive performance seen in the final quarter of its financial 2021 continued into the first quarter of its current financial year.

----------

EPE Special Opportunities Ltd - investment firm - Reports net asset value per share of 542.30p as at July 31e, representing an increase of 24% on the NAV per share of 437.63p as at January 31. The share price stood at 393.00p at the end of July, representing an increase of 45% on the share price of 271.00p as at the end of January. "The performance of the company in the six months ended July 31 was strong despite the ongoing disruption caused by the Covid-19 pandemic. The company has continued to make progress in the existing portfolio and has successfully completed a new investment in the period," says Chair Clive Spears.

----------

RA International Group PLC - remote site services provider - Reports revenue of USD26.2 million for the six months to the end of June, down from USD35.4 million posted the year earlier. Pretax profit declined to USD800,000 from USD1.6 million year-on-year. "We are cautiously optimistic and starting to see encouraging signs that the business environment is improving; depending on timing, this could boost our second half performance, but in any event should bridge to a stronger 2022," says CEO Soraya Narfeldt.

Separately, RA International reports the award of a new contract in a joint venture with ECC, the US based global construction and environmental remediation contractor. The contract with US Navy facilities engineering systems command far east is a five year contract for design and construction services supporting their base on the island of Diego Garcia in the Indian Ocean. The contract ceiling for this award is USD249 million and RA International and ECC will compete for individual task orders with four other awardees.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Aug 2023 11:06

ValiRx interim loss widens as costs increase; hails Inaphaea progress

(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio.

Read more
24 Aug 2023 09:59

ValiRx shares jump as H1 losses shrink

(Sharecast News) - Shares in ValiRx jumped nearly on Thursday after the biotech posted results for its first half, in which losses per share shrunk by a third.

Read more
14 Aug 2023 09:53

ValiRx subsidiary Inaphaea signs deal with Agility Life Sciences

(Sharecast News) - Life science company ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has entered a collaborative services agreement with Agility Life Sciences.

Read more
14 Aug 2023 08:52

ValiRx signs collaborative services agreement with Agility

(Alliance News) - ValiRx PLC on Monday said its wholly-owned subsidiary, Inaphaea BioLabs Ltd, has entered into a collaborative services agreement with Agility Life Sciences Ltd.

Read more
19 Jul 2023 09:39

IN BRIEF: ValiRx subsidiary secures contract with UK biotech firm

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphea BioLabs Ltd will partner with an unnamed UK-based biotechnology company on a phenotypic assay to investigate anti-cancer properties using patient-derived cells from Inaphea's biobank. Adds Inaphea has started internal studies on ValiRx assets s VAL301 and Cytolytix CLX001. "This defined work programme involves a multi-stage project and is expected to complete at the end of September 2023," ValiRx says.

Read more
28 Jun 2023 20:25

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News:

Read more
21 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Braime Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Falcon Oil & Gas LtdAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Robinson PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrant holders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 11:51

IN BRIEF: ValiRx subsidiary to supply cell-based assays to OncoBone

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphaea Biolabs Ltd enters agreement with OncoBone Ltd. Says OncoBone clients will be able to access Inaphaea services. Notes Inaphaea is now confirmed as a cell-based assay supplier to OncoBone. Adds Inaphaea's services are now listed on scientist.com, a database website used by biotechnology and pharmaceutical companies.

Read more
16 Jun 2023 11:14

ValiRx terminates collaboration with Hokkaido University

(Sharecast News) - Life science company ValiRx has officially concluded its evaluation agreement with Hokkaido University, it announced on Friday.

Read more
16 Jun 2023 10:29

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jun 2023 09:09

ValiRx shares drop after cancer drug research dropped

(Alliance News) - ValiRx PLC shares fell on Friday, after it ended its evaluation agreement with Hokkaido University to research a potential drug.

Read more
16 Jun 2023 08:47

LONDON MARKET OPEN: Stocks head higher as pound tops USD1.28 again

(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions.

Read more
14 Jun 2023 14:37

ValiRx acquires assets of in-liquidation Imagen Therapeutics

(Sharecast News) - Life science company ValiRx has successfully completed the acquisition of the scientific assets of Imagen Therapeutics, it announced on Wednesday.

Read more
14 Jun 2023 11:35

ValiRx buys Imagen's scientific assets for cancer screening services

(Alliance News) - ValiRx PLC on Wednesday said it acquired the scientific assets of Imagen Therapeutics Ltd from its appointed liquidators for GBP170,000.

Read more
7 Jun 2023 12:44

ValiRx expands cancer research agreement with University of Barcelona

(Alliance News) - ValiRx PLC on Wednesday said it has expanded a pre-existing agreement with the University of Barcelona to test additional molecules as possible drugs for cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.